We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+7.78%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$633M
AUM Growth
+$33.3M
Cap. Flow
-$5.54M
Cap. Flow %
-0.88%
Top 10 Hldgs %
31.2%
Holding
315
New
15
Increased
70
Reduced
124
Closed
9

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$725K
2
SWKS icon
Skyworks Solutions
SWKS
+$710K
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$655K
4
LMT icon
Lockheed Martin
LMT
+$652K
5
HAIN icon
Hain Celestial
HAIN
+$596K

Top Sells

Rank Stock Value
1
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$1.23M
2
SNDK
SANDISK CORP
SNDK
+$1.07M
3
KMI icon
Kinder Morgan
KMI
+$1.04M
4
HPQ icon
HP
HPQ
+$726K
5
CLVS
Clovis Oncology, Inc.
CLVS
+$633K

Sector Composition

Rank Sector Weight
1 Healthcare 26.13%
2 Industrials 14.48%
3 Consumer Staples 11.04%
4 Financials 9%
5 Technology 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMP
26
DELISTED
Magellan Midstream Partners, L.P.
MMP
$6.1M 0.96%
89,804
-1,055
-1% -$68.4K
GILD icon
27
Gilead Sciences
GILD
$167B
$5.97M 0.94%
58,965
+1,550
+3% +$161K
PFE icon
28
Pfizer
PFE
$144B
$5.97M 0.94%
194,831
-686
-0.4% -$21.6K
WMT icon
29
Walmart Inc
WMT
$900B
$5.96M 0.94%
291,933
-17,205
-6% -$345K
BA icon
30
Boeing
BA
$175B
$5.63M 0.89%
38,958
-276
-0.7% -$39.8K
XOM icon
31
ExxonMobil
XOM
$634B
$5.51M 0.87%
70,741
-2,060
-3% -$165K
SNDK
32
DELISTED
SANDISK CORP
SNDK
$5.45M 0.86%
71,695
-14,600
-17% -$1.07M
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$124B
$4.94M 0.78%
39,270
– –
TMO icon
34
Thermo Fisher Scientific
TMO
$214B
$4.93M 0.78%
34,792
+150
+0.4% +$20K
SPG icon
35
Simon Property Group
SPG
$76.8B
$4.7M 0.74%
24,151
-260
-1% -$50.4K
CSCO icon
36
Cisco
CSCO
$456B
$4.52M 0.71%
166,335
-1,326
-0.8% -$36.6K
EPD icon
37
Enterprise Products Partners
EPD
$83.6B
$4.47M 0.71%
174,637
-1,148
-0.7% -$29.8K
MRK icon
38
Merck
MRK
$326B
$4.17M 0.66%
82,806
+1,083
+1% +$54.6K
IBM icon
39
IBM
IBM
$214B
$4.05M 0.64%
30,762
-2,187
-7% -$294K
EL icon
40
Estee Lauder
EL
$30.7B
$3.98M 0.63%
45,234
– –
T icon
41
AT&T
T
$169B
$3.91M 0.62%
150,377
+12,178
+9% +$309K
CVS icon
42
CVS Health
CVS
$140B
$3.75M 0.59%
38,379
+7,400
+24% +$725K
ACAD icon
43
Acadia Pharmaceuticals
ACAD
$4.45B
$3.73M 0.59%
104,650
+2,140
+2% +$75.4K
ESRX
44
DELISTED
Express Scripts Holding Company
ESRX
$3.66M 0.58%
41,834
-194
-0.5% -$16.6K
MO icon
45
Altria Group
MO
$125B
$3.66M 0.58%
62,804
-597
-0.9% -$34.6K
KSU
46
DELISTED
Kansas City Southern
KSU
$3.61M 0.57%
48,380
+265
+0.6% +$22.6K
RTX icon
47
RTX Corp
RTX
$295B
$3.59M 0.57%
59,443
-2,542
-4% -$154K
WFC icon
48
Wells Fargo
WFC
$263B
$3.51M 0.55%
64,490
+3,500
+6% +$190K
CVX icon
49
Chevron
CVX
$374B
$3.39M 0.54%
37,707
-460
-1% -$41.5K
QQQ icon
50
Invesco QQQ Trust
QQQ
$445B
$3.39M 0.53%
30,268
+500
+2% +$55.8K
1
2
3 4 5

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q4 2015 Portfolio in Review

As of Q4 2015, Gerald L. Ray & Associates held 315 positions worth $633M, up 5.6% from $600M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Gerald L. Ray & Associates's Q4 2015 filing shows 15 new, 70 increased, 124 reduced and 9 closed positions. Its largest new stake was Skyworks Solutions: 8,860 shares worth $681K. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $1.23M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q4 2015 buy was Skyworks Solutions: 8,860 shares worth $681K.
  • Gerald L. Ray & Associates added most to CVS Health in Q4 2015, an estimated $725K increase.
  • Gerald L. Ray & Associates's biggest Q4 2015 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $1.23M.
  • Gerald L. Ray & Associates fully exited Calpine Corporation in Q4 2015, selling an estimated $343K.
  • Gerald L. Ray & Associates's ten largest holdings make up 31% of its $633M portfolio in Q4 2015.
  • Gerald L. Ray & Associates opened 15 new positions and closed 9 in Q4 2015.
  • Gerald L. Ray & Associates's portfolio value rose 5.6% quarter-over-quarter to $633M.

Based on Gerald L. Ray & Associates's 13F filing for Q4 2015, filed 8 Feb 2016.